Ken O'Flynn

636. Deputy Ken O'Flynn asked the Minister for Social Protection the number of applications received for disability allowance in each of the years 2020 to 2025 and to-date in 2026; the number approved; the number refused; and the approval rate in each year, in tabular form. [16711/26]

637. Deputy Ken O'Flynn asked the Minister for Social Protection the number of recipients of disability allowance by primary medical condition category in each of the years 2020 to 2025 and to-date in 2026, in tabular form; and if he will provide the percentage increase or decrease in each category over that period. [16712/26]

638. Deputy Ken O'Flynn asked the Minister for Social Protection the average duration of time recipients have remained on disability allowance; the number of recipients on the scheme for more than five years; and the annual exit rate from the scheme in each of the years 2020 to 2025. [16713/26]

639. Deputy Ken O'Flynn asked the Minister for Social Protection whether any internal administrative guidance, medical assessment protocols, or decision-making frameworks relating to eligibility for disability allowance have been amended, revised, or updated since 1 January 2020; and if so, if he will outline the nature and date of those revisions. [16714/26]

640. Deputy Ken O'Flynn asked the Minister for Social Protection the estimated gross annual expenditure on disability allowance in each of the years 2020 to 2025 and the projected expenditure for 2026. [16715/26]

666. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration whether his Department has issued any policy guidance, circulars, statutory codes or administrative instructions concerning the classification and statistical reporting of offences under section 24 of the Protected Disclosures (Amendment) Act 2022; whether his Department has undertaken any review of the adequacy of national reporting mechanisms for such offences since enactment; and whether legislative amendment is under consideration. [16704/26]

667. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the statistical and reporting framework relied upon by his Department for compiling figures on referrals and prosecutions under section 24 of the Protected Disclosures (Amendment) Act 2022; whether those figures are drawn from offences recorded under a distinct legislative code within national reporting systems; and whether he is satisfied that current categorisation arrangements ensure complete and accurate reporting to the Oireachtas. [16705/26]

848. Deputy Ken O'Flynn asked the Minister for Health the criteria used by the Health Service Executive to define and measure “success” in respect of outcomes arising from elective surgical procedures performed in public hospitals; and if she will make a statement on the matter. [16536/26]

849. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive maintains a comprehensive national record of mortality and morbidity data associated with elective surgical procedures carried out within the public health system; the format in which such data are collected and reported; and if she will make a statement on the matter. [16537/26]

850. Deputy Ken O'Flynn asked the Minister for Health the formal policies, protocols, or governance frameworks in place within the Health Service Executive governing the management and remediation of complications arising from elective surgical procedures performed in Ireland, including the funding and oversight arrangements for remedial treatment; and if she will make a statement on the matter. [16538/26]

880. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken or commissioned any cost-effectiveness analysis comparing high-dose influenza vaccines with standard dose influenza vaccines for adults aged 65 years and over for the 2026/2027 influenza season; if so, the date on which that analysis was completed; whether it informed procurement planning for that season; and if she will make a statement on the matter. [16702/26]

881. Deputy Ken O'Flynn asked the Minister for Health whether her Department has formally requested the National Immunisation Advisory Committee to review high-dose influenza vaccines since 1 January 2025; if so, the date of that request; whether a written record of the request exists; and whether any further review is currently under consideration. [16703/26]

882. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives regular reports from the Health Service Executive on the number, duration of vacancy, and disposal status of residential properties owned by the HSE; the frequency of such reporting; and whether any performance indicators apply to the timely disposal of surplus residential assets. [16750/26]

883. Deputy Ken O'Flynn asked the Minister for Health whether any target timelines exist, at Departmental or HSE level, for the disposal of residential properties deemed surplus to requirements; if not, whether she intends to introduce such timelines in light of properties vacant for periods exceeding ten years. [16751/26]

884. Deputy Ken O'Flynn asked the Minister for Health whether her Department requires the HSE to centrally record and report the annual holding costs associated with vacant residential properties, including insurance, security, and maintenance; and if not, whether she considers this consistent with public financial management best practice. [16752/26]

885. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted, since 2020, any review of the HSE Protocol for the Acquisition and Disposal of Property as published in 2022, with particular regard to disposal timelines and value-for-money safeguards; and if she will provide details of any such review. [16753/26]

917. Deputy Ken O'Flynn asked the Minister for Health the date on which the review of the medicines reimbursement process, as committed to in the Programme for Government, will commence; whether terms of reference has been agreed; whether those terms will explicitly include the assessment and reimbursement framework for orphan medicines; when the review is expected to conclude; and if she will make a statement on the matter. [16943/26]

918. Deputy Ken O'Flynn asked the Minister for Health in light of Rare Disease Day taking place on 28 February, if she will commit to introducing an early access scheme in Ireland for people living with rare diseases to access EMA-approved orphan medicines; if such an early access scheme will include orphan medicines products licenced for non-oncology conditions; and if she will make a statement on the matter. [16944/26]

919. Deputy Ken O'Flynn asked the Minister for Health if the Oversight Implementation Group for the National Rare Disease Strategy has been established, given that the strategy was published in August 2025; and if she will make a statement on the matter. [16945/26]

934. Deputy Ken O'Flynn asked the Minister for Health her plans to commence a review of the reimbursement process, as committed to in the Programme for Government; whether such a review will specifically include the way in which orphan medicines are assessed and reimbursed; and if she will make a statement on the matter. [16987/26]

935. Deputy Ken O'Flynn asked the Minister for Health in light of Rare Disease Day taking place on 28 February 2026, if she will commit to introducing an early access scheme in Ireland for people living with rare diseases to access EMA-approved orphan medicines; if such an early access scheme will include orphan medicines products licenced for non-oncology conditions; and if she will make a statement on the matter. [16988/26]

210. Deputy Ken O'Flynn asked the Minister for Foreign Affairs and Trade further to Parliamentary Question No.189 of 19 February 2026, and reply that her Department has “no affiliation with the referenced website” includes confirmation that, since 1 January 2015, her Department has not received or responded to correspondence from any entity operating under the name ‘Diplomat.ie’; her Department has not held meetings, whether in person or virtual, with any representative of such entity; has not provided any funding, grant assistance, sponsorship, procurement payment, or other financial support to such entity or any associated legal person; and has not authorised any individual associated with that entity to act in any diplomatic, consular, trade, advisory, representative, or quasi-diplomatic capacity on behalf of the State. [15703/26]

211. Deputy Ken O'Flynn asked the Minister for Foreign Affairs and Trade whether her Department calculates, or can calculate from grant financial reports held by her Department, the aggregate proportion of Ireland’s total Official Development Assistance in each of the years 2022, 2023 and 2024 that was retained by implementing partners for programme support costs, overhead, administration, consultancy, or management charges; and if so, to provide the proportion for each year. [15704/26]

212. Deputy Ken O'Flynn asked the Minister for Foreign Affairs and Trade if her Department does not currently calculate a blended effective overhead rate across total Official Development Assistance expenditure, the reason this metric is not produced, the accounting or data constraints that prevent it, and the steps she will take to enable publication of such a rate for each of the years 2022, 2023 and 2024 [15705/26]

213. Deputy Ken O'Flynn asked the Minister for Foreign Affairs and Trade for each of the years 2022, 2023 and 2024, a breakdown of Ireland’s core contributions to multilateral organisations by recipient organisation and amount, and to state for each organisation the standard programme support cost rate, indirect cost recovery rate, or equivalent administrative levy applied to core resources, as published by the organisation or applied contractually, and the estimated euro value associated with that rate for Ireland’s contribution in each year [15706/26]